Evofem Biosciences (EVFM) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts EVFM Hot Sheet
Join SI Premium – FREE
Evofem Biosciences (OTC: EVFM) reported Q1 EPS of $0.00. Revenue for the quarter came in at $850 thousand.
For earnings history and earnings-related data on Evofem Biosciences (EVFM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Primis Financial (FRST) Misses Q3 EPS by 7c
- Cass Information Systems (CASS) Tops Q3 EPS by 1c
- Raymond James Downgrades First Industrial Realty Trust (FR) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
